Pyroptosis is a form of programmed cell death in which an immune cell essentially blows itself up on purpose, spilling inflammatory signals into its surroundings to raise the alarm against infection. Unlike the quiet, tidy self-destruction of apoptosis, pyroptosis is loud and messy: the cell swells, its membrane ruptures, and pro-inflammatory molecules pour out to recruit more immune defenders. First formally described in macrophages and dendritic cells responding to bacterial invasion, the process has since been linked to an expanding list of diseases where the immune system’s own firepower causes collateral damage.
How It Works
Pyroptosis starts inside immune cells when molecular sensors detect something dangerous in the cell’s interior. These sensors, belonging to a family of proteins called NOD-like receptors (including NLRP1, NLRP3, and NLRC4), assemble into large protein complexes called inflammasomes. An inflammasome acts like a switch: once assembled, it activates caspase-1, an enzyme that sets the rest of the process in motion.1PubMed Central. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis Caspase-1 cleaves a protein called gasdermin D, splitting it into two fragments. The freed fragment migrates to the cell’s outer membrane and assembles with copies of itself into a ring-shaped pore. Structural studies show that these pores are made of roughly 31 to 34 subunits and have an inner diameter of about 21.5 nanometers, large enough for inflammatory cytokines to pass through.2PubMed Central. Mechanistic insights into gasdermin pore formation and regulation in pyroptosis Enough pores in the membrane, and the cell bursts.
The pores are not just holes. Structural work has shown that the inner lining of the gasdermin D pore carries a strong negative charge. This matters because the mature, processed forms of the inflammatory cytokines IL-1β and IL-18 carry a positive charge, while their inactive precursor forms carry a negatively charged domain. The pore therefore preferentially lets the active forms through and holds the precursors back, acting as a kind of electrostatic filter. In living macrophages that have not yet fully lysed, this selectivity allows the cell to secrete mature IL-1β without necessarily dying right away.3PubMed Central. Gasdermin D pore structure reveals preferential release of mature interleukin-1
Two Roads to the Same Outcome
The pathway described above, driven by caspase-1 and assembled inflammasomes, is called the canonical pathway. But there is a second route. In the non-canonical pathway, other members of the caspase family (caspase-4 and caspase-5 in humans, caspase-11 in mice) respond to a specific bacterial molecule: lipopolysaccharide, or LPS, which is a major component of the outer membrane of gram-negative bacteria. When LPS turns up loose inside the cell’s interior rather than on a bacterium’s surface, it binds directly to these caspases, triggering their activation without needing a traditional inflammasome complex.4PubMed Central. Mechanisms and Consequences of Noncanonical Inflammasome-Mediated Pyroptosis The result is the same: gasdermin D gets cleaved, pores form, and the cell dies an inflammatory death.5PubMed Central. Caspase-11, a specific sensor for intracellular lipopolysaccharide recognition, mediates the non-canonical inflammatory pathway of pyroptosis
One important wrinkle is that the non-canonical pathway also loops back to the canonical one. Once caspase-11 (or its human equivalents) cleave gasdermin D, the resulting membrane damage triggers NLRP3 inflammasome assembly, which then activates caspase-1 and the processing of IL-1β and IL-18. So the two pathways are not completely independent: the non-canonical arm amplifies the inflammatory signal by piggybacking on the canonical machinery.6The Journal of Immunology. Function and Regulation of Noncanonical Caspase-4/5/11 Inflammasome
Cells Can Patch the Holes
Pyroptosis sounds irreversible, but cells do have a repair mechanism. Calcium ions flooding in through gasdermin D pores act as an emergency signal, causing the cell to recruit a set of membrane-repair proteins known as the ESCRT-III machinery. These proteins can effectively clip out and shed the damaged patch of membrane, removing gasdermin pores before enough of them accumulate to kill the cell. When researchers blocked ESCRT-III activity, pyroptosis and IL-1β release increased dramatically, confirming that membrane repair actively restrains the process.7PubMed. ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation This tug-of-war between pore formation and membrane repair explains how a cell can release some inflammatory cytokines through gasdermin pores without necessarily committing to full-blown lysis. It also means pyroptosis is not simply an on-off switch but a graded response that the cell can, under the right conditions, survive.
This repair mechanism has drawn attention in cancer biology as well. In endometrial carcinoma cells, components of the ESCRT machinery were found to reverse gasdermin D-mediated pyroptosis by remodeling the cell membrane, raising the possibility that some cancers exploit this repair pathway to dodge pyroptotic death.8PubMed. CHMP4B and VSP4A reverse GSDMD-mediated pyroptosis by cell membrane remodeling in endometrial carcinoma
Pyroptosis as Immune Defense
The original evolutionary purpose of pyroptosis appears to be fighting infection. When a bacterium hides inside an immune cell, the cell has a problem: the pathogen is shielded from antibodies and other circulating defenses. Pyroptosis solves this by destroying the safe house. The lysed cell dumps its contents, including the bacteria, into the extracellular space, where other immune cells can find and kill them. The burst of inflammatory cytokines also calls in reinforcements.9PubMed Central. Pyroptosis in defense against intracellular bacteria
Beyond bacteria, killer lymphocytes (natural killer cells and cytotoxic T cells) can trigger pyroptosis in target cells through a separate mechanism. The enzyme granzyme A, delivered by these lymphocytes, cleaves a different gasdermin family member, gasdermin B, to punch pores in target cells. Gasdermin B is highly expressed in digestive tract tissues and in certain tumors, and introducing a cleavable version of it into mouse cancer cells promoted tumor clearance.10PubMed. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells This finding showed that pyroptosis is not only a self-destruct mechanism in immune cells but also a weapon that immune cells can deploy against infected or abnormal cells from the outside.
When It Causes More Harm Than Good
The same inflammatory explosion that fights bacteria can devastate tissues when it spirals out of control. In sepsis, bacterial LPS flooding the bloodstream can trigger widespread pyroptosis in the cells lining blood vessels. In mouse models, deleting gasdermin D specifically from endothelial cells improved survival from 10% to 100% during LPS challenge, a result on par with removing gasdermin D from the entire body.11The Journal of Clinical Investigation. Endothelial GSDMD underlies LPS-induced systemic vascular injury and lethality Separate work confirmed that mice lacking gasdermin D globally showed reduced breakdown of the endothelial barrier, better organ blood flow, and improved survival during endotoxemia.12PubMed. PhospholipaseCγ1/calcium-dependent membranous localization of Gsdmd-N drives endothelial pyroptosis, contributing to lipopolysaccharide-induced fatal outcome The picture that emerges is that in severe infections, pyroptosis in the blood vessel lining itself may be a dominant driver of organ failure and death.
COVID-19 provided a vivid clinical example. SARS-CoV-2-induced pyroptosis in alveolar macrophages drove acute lung injury by pulling waves of neutrophils and inflammatory macrophages into lung tissue, flooding the airways with cytokines like IL-1β and IL-6. The dying cells triggered more death in neighboring cells, fueling the runaway inflammation behind severe pneumonia.13International Journal of Biological Sciences. Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19 In hospitalized patients, serum levels of gasdermin D correlated with the severity of lung damage seen on CT scans, and patients who needed mechanical ventilation or died had higher circulating gasdermin D than those who recovered.14PubMed Central. Serum gasdermin D levels are associated with the chest computed tomography findings and severity of COVID-19
Pyroptosis in the Brain
Microglia, the resident immune cells of the brain, are equipped with the same inflammasome and gasdermin machinery found in other immune cells. In Alzheimer’s disease, amyloid-beta accumulation appears to drive chronic microglial pyroptosis. In a mouse model of Alzheimer’s, silencing a protein called MST1 in brain tissue suppressed inflammasome-driven microglial pyroptosis, reduced inflammatory cytokine release, and improved cognitive function. The mechanism ran through the NLRP1/caspase-1/gasdermin D signaling chain.15PubMed Central. MST1 promotes microglial pyroptosis and neuroinflammation in alzheimer’s disease by regulating the novel DPP8/NLRP1/Caspase-1/GSDMD-N axis
A similar story is emerging in diabetic brain disease. High glucose levels drive NLRP3-dependent microglial pyroptosis, which releases IL-1β and impairs the generation of new neurons in the hippocampus, a brain region critical for learning and memory. In diabetic mice, suppressing NLRP3 in microglia reduced pyroptosis, lowered IL-1β release, rescued new neuron formation, and reversed cognitive deficits.16Acta Pharmacologica Sinica. Microglial NLRP3-dependent pyroptosis promotes cognitive dysfunction of diabetic encephalopathy by inhibiting adult hippocampal neurogenesis through the release of IL-1β These findings suggest that chronic, low-grade pyroptosis in brain immune cells may be a shared mechanism linking neuroinflammation to cognitive decline across multiple conditions.
Atherosclerosis and the Cardiovascular System
Pyroptosis has been observed in cells throughout atherosclerotic plaques, from the earliest fatty streaks to the advanced lesions that cause heart attacks. The levels of pyroptosis-related proteins in plaques correlate with plaque instability, the feature most dangerous for patients because unstable plaques are the ones that rupture and block arteries.17PubMed Central. The emerging role of pyroptosis-related inflammasome pathway in atherosclerosis The inflammatory cytokines released during pyroptosis amplify local inflammation inside the artery wall, recruit more immune cells, and weaken the fibrous cap that holds a plaque together. Pyroptosis in this context is not defending against a pathogen. It is responding to cholesterol crystals and other debris that the inflammasome machinery interprets as danger signals, making it a case of the immune system attacking the body’s own tissues.
The Cancer Paradox
In cancer, pyroptosis plays contradictory roles depending on timing, tumor type, and the broader immune environment. When tumor cells undergo acute pyroptosis, the resulting burst of inflammatory molecules and cellular debris can wake up the immune system. Released danger signals promote the maturation of dendritic cells and attract T cells into the tumor, converting immunologically quiet (“cold”) tumors into inflamed (“hot”) tumors that respond better to immunotherapy.18PubMed Central. Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives Experimental approaches have exploited this idea: delivering bacterial LPS into tumors using nanoparticles to trigger the non-canonical pyroptosis pathway selectively killed cancer cells, boosted T cell infiltration, and suppressed tumor growth in mice.19Nano Letters. Targeting Pyroptosis through Lipopolysaccharide-Triggered Noncanonical Pathway for Safe and Efficient Cancer Immunotherapy
But chronic, smoldering pyroptosis in the tumor microenvironment can have the opposite effect, feeding a cycle of inflammation that promotes tumor survival and suppresses effective immune responses. The impact varies by tumor type, stage, and immune status, making it impossible to call pyroptosis simply pro-tumor or anti-tumor.20PubMed. Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: From mechanisms to therapy This duality has made researchers cautious about blanket strategies to boost pyroptosis in cancer patients; the goal is to trigger it sharply and locally, not to sustain it chronically.
Gasdermin D as a Blood Test
Because gasdermin D fragments are released into the blood when cells undergo pyroptosis, they are being explored as clinical biomarkers. A recently developed assay targeting the C-terminal fragment of gasdermin D (the piece left behind after cleavage) found that plasma levels were significantly elevated in sepsis patients compared to healthy controls, with high sensitivity for distinguishing sepsis from health.21PubMed. A novel Gasdermin D C-terminal neo-epitope as a biomarker for pyroptosis in sepsis The N-terminal fragment (the pore-forming piece) has also been measured in blood. Patients with active adult-onset Still’s disease, a systemic inflammatory condition, showed significantly higher serum levels of gasdermin D N-terminal than healthy controls or patients in remission, and those levels tracked with markers of disease activity like IL-18 and ferritin.22Rheumatology. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still’s disease None of these tests are in routine clinical use yet, but they point toward a future where measuring pyroptosis directly, rather than inferring it from downstream inflammation markers, could help doctors distinguish between types of inflammatory disease and track treatment response.
Blocking the Pathway
Given the damage pyroptosis can cause in sepsis, neurodegeneration, and cardiovascular disease, there is strong interest in drugs that can shut it down. One complication is that gasdermin D is not the only gasdermin capable of forming pores. Researchers found that in mice with a constitutively active NLRP3 inflammasome, knocking out gasdermin D alone was not enough to prevent inflammation when the animals were challenged with LPS or TNF-α. The inflammasome shifted to activating caspase-8 and caspase-3, which cleaved a different family member, gasdermin E, to sustain pore formation and cytokine release. However, disulfiram, an FDA-approved drug originally used for alcohol use disorder, inhibited the cleavage of both gasdermin D and gasdermin E in macrophages and reduced severe inflammation and tissue damage in these mice.23PubMed Central. NLRP3 inflammasome activation triggers gasdermin D-independent inflammation The lesson is that blocking one gasdermin may not be enough; the system has backup routes, and effective therapeutics may need to target broader nodes in the pathway or multiple gasdermins simultaneously.
An Extremely Old Trick
Pyroptosis is far older than the mammalian immune system. Gasdermin-like genes have been found in bacteria, where they defend against bacteriophage (virus) infection using essentially the same playbook: a protease cleaves the gasdermin, the freed fragment punches pores in the cell membrane, and the infected cell dies to stop the phage from spreading. Bacterial gasdermins were stabilized in an inactive state by a buried lipid modification and activated by dedicated caspase-like proteases, closely paralleling the autoinhibition-and-cleavage logic in animal cells.24PubMed Central. Bacterial gasdermins reveal an ancient mechanism of cell death
In animals, gasdermin E appears to be the most ancient family member, with evolutionary analyses tracing the first duplication event to roughly 475 million years ago, before cartilaginous fish and bony fish diverged. From gasdermin E, the family expanded: gasdermin A appeared around 320 million years ago, and later duplicated to produce gasdermins B, C, and D. Each new family member evolved variations in its linker region, allowing activation by different proteases and broadening the range of threats the system could respond to.25PubMed Central. Evolutionary analyses of the gasdermin family suggest conserved roles in infection response despite loss of pore-forming functionality The deepest branch of this family tree, shared between bacteria and animals, suggests that self-sacrificing cell death through membrane pores is one of the oldest anti-infection strategies in biology.26PLOS Biology. An ancient defense mechanism: Conservation of gasdermin-mediated pyroptosis
Occupational and Environmental Triggers
Pyroptosis is not only triggered by infections. Inhaling silica dust, a well-known occupational hazard in mining and construction, activates macrophage pyroptosis in the lungs. Silica particles taken up by macrophages generate reactive oxygen species and activate the NLRP3 inflammasome, leading to gasdermin D cleavage, IL-1β release, and the sustained pulmonary inflammation that characterizes silicosis.27PubMed Central. Acute Silica Exposure Triggers Pulmonary Inflammation Through Macrophage Pyroptosis: An Experimental Simulation More recent work has shown that blocking the upstream signaling pathway that silica activates can alleviate both pyroptosis and the tissue-remodeling changes that lead to fibrosis.28PubMed. Silica-induced innate immune activation drives macrophage pyroptosis and lung inflammation through glycolytic reprogramming Cholesterol crystals in atherosclerosis and uric acid crystals in gout work through overlapping inflammasome pathways, making pyroptosis a common thread linking sterile (non-infectious) inflammation across very different diseases.
Where Pyroptosis Meets Other Death Pathways
For years, researchers treated pyroptosis, apoptosis, and necroptosis as cleanly separate programs. That picture has gotten considerably messier. A growing body of evidence shows that these pathways share molecular components and can activate each other, leading to the concept of PANoptosis, a form of cell death that simultaneously engages features of all three and cannot be fully explained by any one of them alone.29PubMed Central. PANoptosis: Cross-Talk Among Apoptosis, Necroptosis, and Pyroptosis in Neurological Disorders The physical platform for this crosstalk, called the PANoptosome, assembles in response to certain infections or tissue damage and simultaneously fires up caspases from multiple death pathways.30Computational and Structural Biotechnology Journal. From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways This overlap is one reason that blocking a single pathway often fails to prevent cell death entirely: shut down pyroptosis, and the cell may switch to necroptosis or apoptosis instead. The redundancy has practical implications for drug development, because a therapy targeting gasdermin D alone may be outflanked by alternative death routes, as the gasdermin E backup pathway described earlier illustrates.